Alexander Guminski

6PUBLICATIONS
37CO-AUTHORS
Oral medicine and pathologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 28, 2025
Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions.

Saad Ahmad, Dasantha Jayamanne, Sarah Bergamin

|Jun 16, 2025
Development of a First-in-Class Click Chemistry-Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial.

Sangeetha Srinivasan, Nathan A Yee, Maša Alečković

|Mar 12, 2024
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.

Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin

|May 03, 2023
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy.

Jake R Thompson, Julia Lai-Kwon, Rachael L Morton

|Dec 06, 2022
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.

Robert I Haddad, Kevin Harrington, Makoto Tahara

|Aug 20, 2021
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis.

Danny Rischin, Nikhil I Khushalani, Chrysalyne D Schmults

Pageof 1

Frequent Collaborators

1 joint publications

Jake R Thompson

1 joint publications

Julia Lai-Kwon

1 joint publications

Rachael L Morton

1 joint publications

Shahneen Sandhu